CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Beckman Coulter Ireland, Inc. recalls Apo B Reagent

Read the official FDA notice

Published
4 Jun 2025
Units affected
2747 units
Agency
FDA
Country
United States

The hazard

The product Value Assignment Sheet (VAS) is used in calibration of the device. An erroneous value was included in the VAS which has the potential to generate an incorrect APO B patient result which could exceed the total allowable error for the APO B assay (11.6%). The error results in results with a positive bias up to 42%. However, based on the mitigating factors the risk to health is considered to be negligible or limited.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Apo B Reagent, REF: OSR6143

Brand / company
Beckman Coulter Ireland, Inc.
Codes / lots
Lot # 2631/UDI: 15099590010409
Distribution
Worldwide - US Nationwide distribution in the states of AZ, CA, CO, FL, GA, IL, IN, MD, MI, NJ, NY, OH, OK, OR, PA, TX, VA, WA, WV and the countries of Argentina, Australia, Belarus, Belgium, Bulgaria, Canada, China, Czechia, Egypt, Estonia, France, Germany, Ghana, Greece, Hong Kong, India, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Russian Federation, Saudi Arabia, Slovakia, Spain, Switzerland, Taiwan, Province of China, United Kingdom of Great Britain and Northern Ireland, United States of America, Viet Nam.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.